News

The randomized phase III clinical study of Tarceva (erlotinib) plus gemcitabine chemotherapy in patients with locally advanced or metastatic pancreatic cancer, met its primary endpoint by demonstrating a

The phase III study, named E3200, compared Avastin (bevacizumab) plus the FOLFOX4 chemotherapy regimen (oxaliplatin/5-FU/leucovorin), to FOLFOX4 alone in second-line metastatic colorectal cancer patients. Its primary endpoint, met

The company and the FDA agreed upon the phase I study protocol following an exchange of information and discussions centered on Tarvacin’s novel mechanism of action and the

Acyclovir 5% cream is marketed as an over-the-counter (OTC) product in these territories for the treatment of cold sores (herpes labialis). Under the terms of the agreement, Transport

Genecor develops and delivers innovative products and services into the healthcare, agri-processing, industrial and consumer markets. Danisco is to pay DKK 2,413 million ($419 million)in total for Genencor

The BMJ report alleged that Lilly failed to provide the FDA with documents relating to the risks associated with the antidepressant. The apology and retraction references the journal’s

Chiesi-developed CHF1512 (to be known in the future as GT1512) is a methyl-ester of levodopa (LDME), melevodopa, combined with the decarboxylase inhibitor carbidopa. The phase III clinical development

The product candidate has been granted orphan status for the treatment of non-superficial urothelial cancer, the most common form of which is bladder cancer. This designation adds to

The clinical study will evaluate the safety profile and preliminary incidence and duration of clinical benefits of novel escalating dose and administration schedules of Taxotere in combination with